Hookah is a common tobacco product, especially among youth. A research team aimed to better understand the effects of hookah on thrombogenesis. Lead author Fadi Khasawneh, B.Pharm, PhD, answered our...
Consultant360 spoke with the SELECT trial national principal investigator and lead author Amrou Sarraj, MD, whose trial shed light on how the use of imaging modalities can be optimized following the onset...
A study team recently examined the risk of ischemic strokes and transient ischemic attacks among patients who discontinued vitamin K antagonist therapy. We spoke with lead authors Carlos Martinez, MD, MSc,...
Researchers Marianne Hartford, MD, PhD, and Annica Ravn-Fischer, MD, PhD, answer our questions about their latest research that investigated gender differences in outcomes and predictors of acute coronary...
In this Q&A, Jason S. Bradfield, MD, answers our questions about his research on epicardial ablation of ventricular tachycardia and the challenges it currently presents.
During his session at the InterPro AFib Forum, Christian T. Ruff, MD, MPH, from Brigham and Women's Hospital, spoke about managing antithrombotic therapy in AFib and CAD.
Consultant360 recently spoke with Wesley O’Neal, MD, regarding his latest research about the link between provider specialty, anticoagulation prescription patterns, and stroke risk in patients with atrial...
